在接受静脉注射佩加斯帕加斯的儿童和青少年中吐:一项回顾性研究
Jamie M Brown1, Sherry Mathew2, Maria Luisa Sulis3
1Department of Pharmacy, Phoenix Children's, Phoenix, USA.
建议静脉注射佩加斯帕加斯,因为它在儿科患者中具有适度的发泄性. 这项研究发现,在所有接受抗治疗的患者中,都有完整的反应,这表明恶心和吐的有效管理.
科学领域:
- 在瘤学瘤学.
- 儿科瘤学 儿科瘤学
- 临床药理学 临床药理学
背景情况:
- 由于证据不足,静脉注射佩加斯帕加斯的 emetogenicity 以前在儿科指南中未被分类.
- 精确的化学疗法诱导的恶心和吐 (CINV) 的分类对于有效的患者管理至关重要.
研究的目的:
- 在儿科患者中确定静脉注射 (IV) 佩加斯帕加斯的 emetogenicity.
- 在先前的框架内为IV石酸提供基于证据的分类.
主要方法:
- 进行了一个单一中心的回顾性图表审查.
- 这项研究分析了2011年至2020年间接受IV佩加斯帕加斯的44名儿科患者的数据.
- 评估了完全响应 (CR),定义为急性阶段没有吐,特别是在接受抗治疗的患者中.
主要成果:
- 所有13名接受IV佩加斯帕加斯与血清素受体对抗剂加上德克萨米他或帕洛诺塞的儿科患者都实现了完全反应 (CR).
- 这表明抗治疗方案在预防急性恶心和吐方面具有很高的疗效.
结论:
- 基于高的CR率与抗使用,静脉注射的pegaspargase被推归类为中度发的.
- 这一发现解决了关键的证据缺口,并有助于完善儿童瘤学CINV指南.
更多相关视频
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
09:02Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
